Literature DB >> 20729905

Antigen-non-specific regulation centered on CD25+Foxp3+ Treg cells.

Gangzheng Hu1, Zhongmin Liu, Changqing Zheng, Song Guo Zheng.   

Abstract

CD4(+)CD25(+)Foxp3(+) regulatory T cells (Tregs) are of special interest in immunology because of their potent inhibitory function. Many fundamental aspects of Tregs, including their antigenic profile, development and peripheral homeostasis, remain highly controversial. Here, we propose a Treg-centered antigen-non-specific immunoregulation model focused on the T-cell system, particularly on CD4(+) T cells. The T-cell pool consists of naive T cells (Tnais), Tregs and effector T cells (Teffs). Regardless of antigen specificity, the ratio of the activated T-cell subsets (Treg/Teff/Tnai) and their temporal and spatial uniformity dictate the differentiation of Tnais. Activated Tregs inhibit the activation, proliferation, induction and activity of Teffs; in contrast, activated Teffs inhibit the induction of Tregs from Tnais but cooperate with Treg-specific antigens to promote the proliferation and activity of Tregs. In many cases, these interactions are antigen-non-specific, whereas the activation of both Tregs and Teffs is antigen-specific. Memory T-cell subsets are essential for the maintenance of adaptive immune responses, but the antigen-non-specific interactions among T-cell subsets may be more important during the establishment of the adaptive immune system to a newly encountered antigen. This is especially important when new and memory antigens are presented closely-both temporally and spatially-to T cells, because there are always baseline levels of activated Tregs, which are usually higher than levels of memory T cells for new antigens. Based on this hypothesis, we further infer that, under physiological conditions, Tregs in lymph nodes mainly recognize antigens frequently released from draining tissues, and that these self-reactive Tregs are commonly involved in the establishment of adaptive immunity to new antigens and in the feedback control of excessive responses to pathogens.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729905      PMCID: PMC3094156          DOI: 10.1038/cmi.2010.39

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  29 in total

1.  Alloantigen-induced CD25+CD4+ regulatory T cells can develop in vivo from CD25-CD4+ precursors in a thymus-independent process.

Authors:  Mahzuz Karim; Cherry I Kingsley; Andrew R Bushell; Birgit S Sawitzki; Kathryn J Wood
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

2.  Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells.

Authors:  Chandrashekhar Pasare; Ruslan Medzhitov
Journal:  Science       Date:  2003-01-16       Impact factor: 47.728

3.  Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function.

Authors:  Angela M Thornton; Erin E Donovan; Ciriaco A Piccirillo; Ethan M Shevach
Journal:  J Immunol       Date:  2004-06-01       Impact factor: 5.422

4.  Recognition of the peripheral self by naturally arising CD25+ CD4+ T cell receptors.

Authors:  Chyi-Song Hsieh; Yuqiong Liang; Aaron J Tyznik; Steven G Self; Denny Liggitt; Alexander Y Rudensky
Journal:  Immunity       Date:  2004-08       Impact factor: 31.745

5.  Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10.

Authors:  Song Guo Zheng; Ju Hua Wang; J Dixon Gray; Harold Soucier; David A Horwitz
Journal:  J Immunol       Date:  2004-05-01       Impact factor: 5.422

6.  Enhanced regulatory T cell activity is an element of the host response to injury.

Authors:  Niamh Ni Choileain; Malcolm MacConmara; Yan Zang; Thomas J Murphy; John A Mannick; James A Lederer
Journal:  J Immunol       Date:  2006-01-01       Impact factor: 5.422

7.  Specific T regulatory cells display broad suppressive functions against experimental allergic encephalomyelitis upon activation with cognate antigen.

Authors:  Ping Yu; Randal K Gregg; J Jeremiah Bell; Jason S Ellis; Rohit Divekar; Hyun-Hee Lee; Renu Jain; Hanspeter Waldner; John C Hardaway; Mary Collins; Vijay K Kuchroo; Habib Zaghouani
Journal:  J Immunol       Date:  2005-06-01       Impact factor: 5.422

Review 8.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses.

Authors:  Shimon Sakaguchi
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

9.  Continuous activation of autoreactive CD4+ CD25+ regulatory T cells in the steady state.

Authors:  Sylvain Fisson; Guillaume Darrasse-Jèze; Elena Litvinova; Franck Septier; David Klatzmann; Roland Liblau; Benoît L Salomon
Journal:  J Exp Med       Date:  2003-08-25       Impact factor: 14.307

10.  In vivo instruction of suppressor commitment in naive T cells.

Authors:  Irina Apostolou; Harald von Boehmer
Journal:  J Exp Med       Date:  2004-05-17       Impact factor: 14.307

View more
  11 in total

1.  A protocol to develop T helper and Treg cells in vivo.

Authors:  Weiqian Chen; Zhenjian Xu; Yongjiang Zheng; Julie Wang; Wenbin Qian; Nancy Olsen; David Brand; Jin Lin; Song Guo Zheng
Journal:  Cell Mol Immunol       Date:  2017-10-30       Impact factor: 11.530

2.  Anti-inflammatory effects of Boletus edulis polysaccharide on asthma pathology.

Authors:  Songquan Wu; Guangli Wang; Ruhui Yang; Yubao Cui
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

Review 3.  CD8 T-cell regulation by T regulatory cells and the programmed cell death protein 1 pathway.

Authors:  Pablo Penaloza-MacMaster
Journal:  Immunology       Date:  2017-04-25       Impact factor: 7.397

4.  5-Lipoxygenase activity increases susceptibility to experimental Paracoccidioides brasiliensis infection.

Authors:  Fabrine Sales Massafera Tristão; Fernanda Agostini Rocha; Ana Paula Moreira; Fernando Queiroz Cunha; Marcos Antonio Rossi; João Santana Silva
Journal:  Infect Immun       Date:  2013-02-04       Impact factor: 3.441

5.  Cyclic adenosine monophosphate involvement in low-dose cyclophosphamide-reversed immune evasion in a mouse lymphoma model.

Authors:  Ai-Xia Dou; Li-Li Feng; Xiao-Qian Liu; Xin Wang
Journal:  Cell Mol Immunol       Date:  2012-09-24       Impact factor: 11.530

6.  CD19+CD24hiCD38hi regulatory B cells: a potential immune predictive marker of severity and therapeutic responsiveness of hepatitis C.

Authors:  Qiannan Fang; Yanan Deng; Rongzhen Liang; Yongyu Mei; Zhaoxia Hu; Julie Wang; Jianbo Sun; Xiaohong Zhang; Joseph A Bellanti; Song Guo Zheng
Journal:  Am J Transl Res       Date:  2020-03-15       Impact factor: 4.060

7.  Human Gingiva-Derived Mesenchymal Stem Cells Inhibit Xeno-Graft-versus-Host Disease via CD39-CD73-Adenosine and IDO Signals.

Authors:  Feng Huang; Maogen Chen; Weiqian Chen; Jian Gu; Jia Yuan; Yaoqiu Xue; Junlong Dang; Wenru Su; Julie Wang; Homayoun H Zadeh; Xiaoshun He; Limin Rong; Nancy Olsen; Song Guo Zheng
Journal:  Front Immunol       Date:  2017-02-02       Impact factor: 7.561

8.  Mycobacterium tuberculosis infection interferes with HIV vaccination in mice.

Authors:  Lech Ignatowicz; Jolanta Mazurek; Chaniya Leepiyasakulchai; Markus Sköld; Jorma Hinkula; Gunilla Källenius; Andrzej Pawlowski
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

9.  Tim-3 expression defines regulatory T cells in human tumors.

Authors:  Jing Yan; Yi Zhang; Jing-Ping Zhang; Jing Liang; Lian Li; Limin Zheng
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

10.  The regulatory T cells induction by epicutaneous immunotherapy is sustained and mediates long-term protection from eosinophilic disorders in peanut-sensitized mice.

Authors:  V Dioszeghy; L Mondoulet; V Dhelft; M Ligouis; E Puteaux; C Dupont; P-H Benhamou
Journal:  Clin Exp Allergy       Date:  2014-06       Impact factor: 5.018

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.